These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
49 related items for PubMed ID: 5970798
21. Nalidixic acid-resistant Salmonella typhi in Mumbai. Rodrigues C, Mehta A, Joshi VR. Natl Med J India; 1999; 12(2):88. PubMed ID: 10416332 [No Abstract] [Full Text] [Related]
22. Fluoroquinolone resistance in Streptococcus pneumoniae. Peterson DE, Sahm DF. N Engl J Med; 1999 Nov 11; 341(20):1547; author reply 1547-8. PubMed ID: 10577110 [No Abstract] [Full Text] [Related]
24. [On the scope of action of some new quaternary oxyquinoline compounds as bacteriostatic agents]. Müller HD. Arch Exp Veterinarmed; 1965 Apr 11; 19(1):351-5. PubMed ID: 5833342 [No Abstract] [Full Text] [Related]
25. [On the oxidation of acetylacetic acid in escherichia coli]. LENTI C. Boll Soc Ital Biol Sper; 1947 Apr 11; 23(3):296. PubMed ID: 18919631 [No Abstract] [Full Text] [Related]
26. [On the bacteriostatic activity of acetylacetic asters]. Soleil J, Marchal JG, Loppinet V. Ann Inst Pasteur (Paris); 1966 Sep 11; 111(3):373-5. PubMed ID: 5970798 [No Abstract] [Full Text] [Related]
27. The future control of bacterial resistance to antimicrobial agents. Andremont A. Am J Infect Control; 2001 Aug 11; 29(4):256-8. PubMed ID: 11486268 [No Abstract] [Full Text] [Related]
28. Antibacterial resistance worldwide: causes, challenges and responses. Levy SB, Marshall B. Nat Med; 2004 Dec 11; 10(12 Suppl):S122-9. PubMed ID: 15577930 [Abstract] [Full Text] [Related]
29. [Mechanism of action and resistance to fluoroquinolones]. Alarcón T, López-Brea M. Enferm Infecc Microbiol Clin; 1996 Feb 11; 14(2):111-7. PubMed ID: 8714159 [No Abstract] [Full Text] [Related]
30. Quinolone resistance: a practical perspective. Wood CA. Arch Intern Med; 1993 Jan 11; 153(1):120-1. PubMed ID: 8422194 [No Abstract] [Full Text] [Related]
31. [On the bacteriostatic activity of acetylacetic asters]. Soleil J, Marchal JG, Loppinet V. Ann Inst Pasteur (Paris); 1966 Sep 11; 111(3):373-5. PubMed ID: 5970798 [No Abstract] [Full Text] [Related]
32. The future control of bacterial resistance to antimicrobial agents. Andremont A. Am J Infect Control; 2001 Aug 11; 29(4):256-8. PubMed ID: 11486268 [No Abstract] [Full Text] [Related]
33. Antibacterial resistance worldwide: causes, challenges and responses. Levy SB, Marshall B. Nat Med; 2004 Dec 11; 10(12 Suppl):S122-9. PubMed ID: 15577930 [Abstract] [Full Text] [Related]
34. [Mechanism of action and resistance to fluoroquinolones]. Alarcón T, López-Brea M. Enferm Infecc Microbiol Clin; 1996 Feb 11; 14(2):111-7. PubMed ID: 8714159 [No Abstract] [Full Text] [Related]
35. Quinolone resistance: a practical perspective. Wood CA. Arch Intern Med; 1993 Jan 11; 153(1):120-1. PubMed ID: 8422194 [No Abstract] [Full Text] [Related]
36. [On the bacteriostatic activity of acetylacetic asters]. Soleil J, Marchal JG, Loppinet V. Ann Inst Pasteur (Paris); 1966 Sep 11; 111(3):373-5. PubMed ID: 5970798 [No Abstract] [Full Text] [Related]
37. The future control of bacterial resistance to antimicrobial agents. Andremont A. Am J Infect Control; 2001 Aug 11; 29(4):256-8. PubMed ID: 11486268 [No Abstract] [Full Text] [Related]
38. Antibacterial resistance worldwide: causes, challenges and responses. Levy SB, Marshall B. Nat Med; 2004 Dec 11; 10(12 Suppl):S122-9. PubMed ID: 15577930 [Abstract] [Full Text] [Related]
39. [Mechanism of action and resistance to fluoroquinolones]. Alarcón T, López-Brea M. Enferm Infecc Microbiol Clin; 1996 Feb 11; 14(2):111-7. PubMed ID: 8714159 [No Abstract] [Full Text] [Related]
40. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects. Gootz TD, Brighty KE. Med Res Rev; 1996 Sep 11; 16(5):433-86. PubMed ID: 8865150 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]